An overview of the biological disease modifying drugs available for arthritic conditions in South Africa
The past decade has seen a major change in the treatment options and strategies for rheumatoid arthritis (RA) and the other immune-mediated arthritic diseases. The disease modifying antirheumatic drugs (DMARDs) are now used in early stages of the disease in order to preserve joint architecture. Ther...
Enregistré dans:
Auteurs principaux: | Leonie Harmse, Helmuth Reuter |
---|---|
Format: | article |
Langue: | EN |
Publié: |
AOSIS
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1248f4fe9d1e473a9708a3ac6323da8f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
par: A. A. Alshevskaya, et autres
Publié: (2012) -
Management of chronic ocular sarcoidosis: challenges and solutions
par: Matsou A, et autres
Publié: (2018) -
Biological evaluation of novel 6-Arylbenzimidazo [1,2-c] quinazoline derivatives as inhibitors of LPS-induced TNF- alpha secretion
par: GALARCE,GLORIA D, et autres
Publié: (2008) -
The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
par: Georgios Kokolakis, et autres
Publié: (2021) -
Immunological strategy for detecting the pro-inflammatory cytokine TNF-alpha in salmonids
par: Rojas,Verónica, et autres
Publié: (2012)